Found: 15
Select item for more details and to access through your institution.
Diabetes-related distress and quality of life among people with type 2 diabetes at primary care level in Brazil.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 4, p. 461, doi. 10.1007/s00592-023-02216-7
- By:
- Publication type:
- Article
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 4108, doi. 10.3390/ijms25074108
- By:
- Publication type:
- Article
High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 2, p. 1290, doi. 10.3390/ijms25021290
- By:
- Publication type:
- Article
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01584-8
- By:
- Publication type:
- Article
Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01264-z
- By:
- Publication type:
- Article
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.
- Published in:
- Health Economics Review, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13561-023-00466-3
- By:
- Publication type:
- Article
Effect of aluminum accumulation on bone and cardiovascular risk in the current era.
- Published in:
- PLoS ONE, 2023, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0284123
- By:
- Publication type:
- Article
HDL-Targeted Therapies During Myocardial Infarction.
- Published in:
- Cardiovascular Drugs & Therapy, 2019, v. 33, n. 3, p. 371, doi. 10.1007/s10557-019-06865-1
- By:
- Publication type:
- Article
Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 4, p. 814, doi. 10.3390/diagnostics12040814
- By:
- Publication type:
- Article
Advanced Glycation End Products and Bone Metabolism in Patients with Chronic Kidney Disease.
- Published in:
- JBMR Plus, 2023, v. 7, n. 3, p. 1, doi. 10.1002/jbm4.10727
- By:
- Publication type:
- Article
Reference values of skin autofluorescence advanced glycation end-products in healthy and chronic kidney disease individuals: a propensity score matching analysis.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Aspirin in primary prevention and the risk of heart failure: a systematic review and meta‐analysis of controlled trials.
- Published in:
- ESC Heart Failure, 2023, v. 10, n. 2, p. 1488, doi. 10.1002/ehf2.14269
- By:
- Publication type:
- Article
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus.
- Published in:
- Nutrition & Diabetes, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41387-021-00160-5
- By:
- Publication type:
- Article
Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial.
- Published in:
- Diabetology & Metabolic Syndrome, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13098-019-0457-3
- By:
- Publication type:
- Article
Intersoftware variability impacts classification of cardiac PET exams.
- Published in:
- 2019
- By:
- Publication type:
- journal article